IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000

Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin

Joseph W. Eschbach, Joan C. Egrie, Michael R. Downing et al. · New England Journal of Medicine · 1987 · 2K citations

Medicine, Hematology, Pharmacotherapy +17

The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

Anatole Besarab, W. Kline Bolton, Joan C. Egrie et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS

C. Winearls, MartinJ Pippard, M R Downing et al. · The Lancet · 1986 · 1.4K citations

Medicine, Genetics, Nephrology +9

Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease

J. W. Eschbach, MOHAMED H. ABDULHADI, Jeffrey K. Browne et al. · Annals of Internal Medicine · 1989 · 809 citations

Medicine, Hematology, Pharmacotherapy +16

Impact of left ventricular hypertrophy on survival in end-stage renal disease

J. Silberberg, Paul E. Barré, Sarah Prichard et al. · Kidney International · 1989 · 783 citations · Full text

Medicine, Cardiology, Nephrology +13